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Abstract
Chinese herbal medicine (中草藥) attracts much attention in the treatment of liver injuries. Numerous studies have 
revealed various biological activities of medicinal mushrooms such as Antrodia Cinnamomea (牛樟芝). Although A. 
cinnamomea is rare in the wild, recent developments in fermentation and cultivation technologies make the mycelia 
and fruiting bodies of this valuable medicinal mushroom readily available. Liver diseases such as fatty liver, hepatitis, 
hepatic fibrosis, and liver cancer are complicated processes of liver injuries that have tremendous impact on human 
society. In this article, we reviewed studies about the hepatoprotective effects of the fruiting bodies and mycelia of A. 
cinnamomea performed in different experimental models. The results of those studies suggest the potential application 
of A. cinnamomea in preventing and treating liver diseases and its potential to be developed into health foods or new 
drugs.
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Introduction
Several medicinal mushrooms are known to be 
valuable for their effectiveness in the treatment of 
diseases. Among the popular medicinal mushrooms 
such as Antrodia Cinnamomea (Figure 1), Ganoderma 
lucidum, Cordyceps sinensis, and Phellinus linteus, 
A.  cinnamomea  can be found only in Taiwan. 
Antrodia Cinnamomea is used to treat liver diseases, 
hypertension, abdominal pain, diarrhea, and other 
diseases (Ao et al., 2009). Historically, indigenous 
Taiwanese people have used A. cinnamomea  to 
ameliorate liver disorders from excessive alcohol 
consumption. However, it is now becoming more 
difficult to collect wild A. cinnamomea fruiting bodies.
With the development of fermentation technology, 
the mycelia of many medicinal mushrooms can now 
be obtained through submerged fermentation. This 
technology can effectively manage the identity and 
purity of medicinal mushrooms without contamination. 
The process of substrate bag culture for growing 
Figure 1. Antrodia Cinnamomea fruiting bodies grown on wood.
This is an open access article under the CC BY-NC-ND license.
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Table 1. Reported bioactivities of Antrodia Cinnamomea.
Bioactivities Sources References
Antiadenocarcinoma Ethanol extract of fruiting bodies Chen et al., 2012aChen et al., 2012b
Antiallergy Polysaccharide from solid-state-cultured mycelia Liu et al., 2010
Anti-breast cancer
Submerged fermentation culture Lee et al., 2012
Synthesized camphorataimide B (originally isolated from mycelia) Lin et al., 2012
Anti-colon cancer
4,7-Dimethoxy-5-methyl-1,3-
benzodioxole (SY-1) isolated from fruiting bodies Tu et al., 2012
SY-1 derivatives Lien et al., 2011
Antihypertension Hot water extract of mycelia Wang et al., 2003
Antileukemia
Dehydroeburicoic acid isolated from the triterpenoid-rich fraction of the ethanolic 
extracts of fruiting bodies Du et al., 2012
Methanol extract of mycelia Wen et al., 2012
MMH01 
(24-methylenelanosta-7,9(11)-
diene-3β15α-diol-21-oic acid) isolated from fruiting bodies
Chen et al., 2009
Anti-liver cancer
Fruiting bodies
Hsu et al., 2007
Hsieh et al., 2010
Hsieh et al., 2011
Mycelia
Lin et al., 2010
Lin et al., 2011
Song et al., 2005a
Song et al., 2005b
Antroquinonol (originally isolated from solid-state-cultured mycelia) Chiang et al., 2010
Anti-non-small cell lung cancer
Alcohol extract of fruiting bodies Chiou et al., 2011
Alcohol extract of mycelia Chan et al., 2010
Anti-inflammation
Mycelium polysaccharides Chen et al., 2007
Methanolic extract of fruiting bodies Liu et al., 2007
Compounds isolated from fruiting bodies Shen et al., 2007
Compounds isolated from fruiting bodies Chien et al., 2008
Fermentation filtrate Hseu et al., 2010
Ergostatrien-3 -ol (ST1) isolated from submerged fermentation whole broth Huang et al., 2010a
Antioxidant Aqueous extract of mycelia Hseu et al., 2008
Hepatoprotection against CCl4-
induced liver injury
Aqueous extract of fruiting bodies Hsiao et al., 2003
Fermention filtrate 
Song and Yen, 2003
Lin et al., 2006
Hepatoprotection against ethanol-
induced liver injury
Mycelia Lu et al., 2007
Ethanolic extract of mycelia Lu et al., 2011
Ethanolic extract of mycelia Kumar et al., 2011
Fruiting bodies Wu et al., 2011
Methanolic extract of fruiting bodies Huang et al., 2010a
Neuroprotection
Compounds isolated from the methanolic extract of fruiting bodies Chen et al., 2006
Fruiting bodies Wang et al., 2012
Immunomodulation Hot water extract of mycelia Kuo et al., 2008
fruiting bodies also uses liquid fermentation to provide 
the seed medium (Sharma et al., 2005). However, the 
medicinal effectiveness and applicability of the different 
compounds contained in fruiting bodies and mycelia 
remain debatable.
In this review, we discuss the hepatoprotective 
activities of A. cinnamomea in animal models of carbon 
tetrachloride (CCl4)- and alcohol-induced liver injuries, 
as well as its in vitro anti-liver cancer activity.
The liver is the largest organ responsible for 
a spectrum of functions, including the uptake, 
metabolism, conjugation, and excretion of various 
endogenous and foreign substances (Hoekstra et al., 
2012). Chronic hepatitis or toxification leads to severe 
liver injury. The damaged hepatocytes are initially 
denatured and then undergo fibrosis and necrosis. This 
process eventually leads to hepatoma (Friedman, 1997).
Antrodia Cinnamomea , a species of the genus 
Antrodia (Polyporaceae), is a parasitic fungus that lives 
in the inner cavity of Cinnamomum kanehirai, which is 
endemic to Taiwan. Antrodia Cinnamomea is believed 
to be one of the most potent liver-protecting herbs in 
Taiwan (Ao et al., 2009).
Numerous reports have been published on the 
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chemical components of A. cinnamomea. Compounds 
isolated from this mushroom, such as benzenoids, 
diterpenes, triterpenoids, steroids, maleic/succinic acid 
derivatives, and polysaccharides, have been reported to 
exhibit some biological activities.
Table 1 summarizes the reported biological 
activities of A. cinnamomea , including antiallergy, 
anticancer, antihypertension, anti-inflammation, 
antioxidation, hepatoprotection, neuroprotection, and 
immunomodulation.
Antrodia Cinnamomea  and $ lcohol-
induced /iver ,njury
Alcohol liver disease (ALD) is a kind of liver injury 
induced by alcohol drinking, which remains one of 
the most common causes of chronic liver disease 
worldwide. ALD includes steatosis (fatty liver), 
steatohepatitis (alcoholic hepatitis), and cirrhosis (Day 
and Yeaman, 1994). Steatosis is the earliest response of 
the liver to excessive alcohol use and is characterized by 
the accumulation of fat in hepatocytes. Steatohepatitis is 
characterized by infiltration of inflammatory cells into 
hepatocytes and hepatocellular injury (Gao and Bataller, 
2011). Alcohol consumption suppresses the antifibrotic 
effects of natural killer cells and interferon-γ, and 
therefore enhances the progression of liver fibrosis 
(Jeong et al., 2008).
Alcohol promotes the accumulation of fat in the 
liver mainly by the substitution of ethanol for fatty 
acids as the major hepatic fuel (Baraona and Lieber, 
1979). Ethanol increases the fatty acid synthesis 
by acetaldehyde through the upregulation of sterol 
regulatory element-binding protein 1c (SREBP-
1c). AMP-activated protein kinase (AMPK) (You et 
al., 2004), sirtuin 1 (You et al., 2008), adiponectin 
(You, 2009), and signal transducer and activator of 
transcription 3 (STAT3) (Horiguchi et al., 2008) were 
reported to be downregulated by alcohol. The DNA-
binding and transcriptional activation activities of 
peroxisome proliferator-activated receptor-α, a nuclear 
hormone receptor, in hepatocytes are directly inhibited 
by acetaldehyde (Galli et al., 2001).
Three main pathways are involved in the metabolism 
of ethanol: the alcohol dehydrogenase (ADH) pathway 
in the cytosol, the microsomal ethanol-oxidizing 
system (MEOS) in the endoplasmic reticulum, and the 
catalase pathway in peroxisomes (Jiménez-López et 
al., 2002). The ADH pathway is the major metabolic 
pathway during the early stage of chronic alcohol liver 
injury. During the ADH-mediated oxidation of ethanol, 
hydrogen is transferred from the substrate to the cofactor 
nicotinamide adenine dinucleotide (NAD), resulting 
in excess conversion to its reduced form (NADH) 
with the production of acetaldehyde (Cronholm et al., 
1988). Excess NADH changes the redox state and leads 
to metabolic irregularity in the liver. The increase in 
α-glycerophosphate level and the suppression of the 
citric acid cycle are due to the elevated NADH-to-
NAD ratio, thus favoring the accumulation of hepatic 
triglycerides in the liver (Ao et al., 2009). In the early 
1960s, Lieber et al. (1963) formulated a liquid ethanol 
diet and used experimental models to study ethanol-
induced hepatotoxicity. Therefore, the hepatoprotective 
effects of herbs, natural products, and chemicals have 
been widely investigated using these models.
In Taiwan, A. cinnamomea is believed to effectively 
ameliorate liver disorders induced by excessive alcohol 
consumption. However, the effects of A. cinnamomea, 
either its fruiting bodies or mycelia, on alcohol-induced 
liver injuries have only recently been reported (Huang et 
al., 2010a; Lu et al., 2007, 2011; Kumar et al., 2011; Wu 
et al. 2011).
Hepatoprotective (ffect of A. cinnamomea 
)ruiting %odies $gainst $lcohol-induced 
/iver ,njury
The effects of A. cinnamomea  fruiting bodies on 
alcohol-induced liver damage have been reported. 
Huang et al. (2010a) investigated the effects of A. 
cinnamomea  fruiting bodies in a chronic alcohol 
consumption model. Alcoholic fatty liver disease was 
induced by adding 20% (w/w) alcohol to the drinking 
water of experimental rats. Antrodia Cinnamomea 
fruiting body (0.1 g per kilogram body weight per day 
[g•kg BW-1•day-1]) orally administered to the chronic 
alcohol consumption group for 4 weeks increased 
the levels of fecal cholesterol and bile acid. The gene 
expression of 3-hydroxy-3-methoxyglutaryl-CoA 
reductase, SREBP-1c, acetyl-CoA carboxylase, fatty 
acid synthase, and malic enzyme was downregulated by 
A. cinnamomea fruiting body. The results of histological 
examination revealed that the alcohol-induced liver 
injuries, i.e., hepatocyte necrosis and inflammatory cell 
infiltration, were prevented by A. cinnamomea fruiting 
body (0.1 g•kg BW-1•day-1) and that its effect was even 
better than that of silymarin (0.25 g•kg BW-1•day-1).
Wu et al. (2011) investigated the beneficial effects of 
A. cinnamomea fruiting bodies on alcohol-induced liver 
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fibrosis. The expression of hepatic mRNAs, i.e., matrix 
metalloproteinase (MMP)-9, tumor necrosis factor 
(TNF)-α, Kruppel-like factor (KLF)-6, and transforming 
growth factor (TGF)-β1, were downregulated by orally 
administered A. cinnamomea  fruiting bodies (0.025 
g/kg BW, once a day ). The hepatoprotective effect of A. 
cinnamomea fruiting bodies (0.025 g/kg BW, once a day 
) was comparable to that of silymarin (0.25 g/kg BW, 
once a day). This protective effect might account for the 
acceleration of alcohol clearance and the suppression of 
ethanol-induced elevation of MMP-9, TNF-α, KLF-6, 
and TGF-β1 levels.
Hepatoprotective (ffect of A. cinnamomea 
0ycelia $gainst $lcohol-induced /iver ,njury
Lu et al. (2007) reported the effects of A. cinnamomea 
mycelia against ethanol-induced liver injury. Male 
Sprague-Dawley (SD) rats were orally administered 
with 0.5 and 1.0 g/kg BW of  A.  c innamomea 
mycelia for 10 days. At the end of 10th day, rats 
were administered with ethanol (5.0 g/kg BW) by 
gavage to induce acute hepatic injury. The levels of 
serum aspartate aminotransferase (AST), alanine 
aminotransferase (ALT), alkaline phosphatase (ALP), 
and bilirubin in rats given A. cinnamomea  were 
comparable with the silymarin positive group (0.1 g/kg 
BW). Thus, A. cinnamomea showed hepatoprotective 
activity in this acute ethanol-induced liver injury 
rat model. Lu et al. (2011) further reported that a 
triterpenoid-enriched fraction of the ethanolic extract 
of A. cinnamomea  mycelia showed the greatest 
effectiveness in preventing ethanol-induced acute liver 
injury and free radical generation in rats.
Kumar et al. (2011) evaluated the effect of the 
ethanolic extract of A. cinnamomea  in ethanol-
induced acute hepatotoxicity. Ethanolic extracts of A. 
cinnamomea mycelia (0.25, 0.5, and 1 g/kg BW, once a 
day) were orally administered to rats by gavage for 10 
days. Silymarin (0.2 g/kg BW) was used as a positive 
control. After the final administration, hepatotoxicity 
was induced by administering ethanol (5 g/kg BW) 
through oral gavage. The results showed that the 
serum levels of ALT and AST in the group given the 
ethanolic extract of A. cinnamomea (1 g/kg BW) were 
comparable to those in the silymarin positive group 
(0.2 g kg BW). The levels of protein expression of 
hemeoxygenase-1 (HO-1) and NF-E2 related factor-2 
(Nrf-2) were increased in groups orally administered 
with A. cinnamomea ethanolic extract and silymarin. 
The transcription factor Nrf-2 can induce the expression 
of a variety of cytoprotective and detoxifying 
genes (e.g., HO-1 ). This study suggested that the 
hepatoprotective effects of A. cinnamomea ethanolic 
extract might be through a mechanism that involves 
Nrf-2 activation and upregulation of the expression of 
the downstream antioxidant gene.
Figure 2 shows the hepatoprotective mechanisms of 
A. cinnamomea against ethanol-induced liver injuries 
according to the above results. 
Ethanol
ХSREBP-1c
ЦAMPK
ЦSirtuin 1
ЦSTAT3
Fatty liverLiver fibrosis
Fatty acid synthesis
ADH
NAD
Triglyceride
accumulation
Fruiting bodies
of A. cinnamomea
Liver injury
ЦSREBP-1c
Fruiting bodies
of A. cinnamomea
ĻMMP-9
ĻTNF-Į
ĻKLF-6
ĻTGF-ȕ1Mycelia of A.
cinnamomea
ХHO-1
ХNrf-2
Figure 2. Mechanisms of fruiting bodies and mycelia of Antrodia Cinnamomea against ethanol-induced liver injuries.
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Antrodia Cinnamomea and CCl4-induced 
/iver ,njury
Chronic CCl4 treatment causes liver injury, oxidative 
stress, and nitrosative stress. Collagen accumulation, 
which causes hepatic fibrosis, was also found to be a 
result of chronic CCl4 treatment (Tipoe et al., 2010). 
The hepatotoxicity of CCl4 consists of 2 steps. The first 
step involves the production of free radicals (CCl3• and 
CCl3OO•) through hepatic metabolism mediated by the 
cytochrome P450 system. The second phase involves 
the activation of Kupffer cells, which is accompanied 
by the production of inflammatory and profibrogenic 
media to rs .  Cytochrome P450  2E1 (CYP2E1) 
knockout mice (cyp2e1-/-) were used to investigate the 
involvement of CYP2E1 in the development of CCl4-
induced hepatotoxicity, and CYP2E1 was found to be 
a major factor in CCl4-induced hepatotoxicity in mice 
(Wong et al., 1998).
The enzymatic activation of CCl4, leading to the 
generation of CCl3 radicals, also disrupts the structure 
and function of lipids and proteins in the membrane 
and cell organelles (Xiao et al., 2012). The injured 
hepatic tissue is thus degraded by MMPs, while tissue 
inhibitor of MMPs (TIMPs) act as regulators of MMPs, 
preventing further degradation and damage to the newly 
synthesized collagen and unaffected tissue (Hemmann 
et al., 2007). CCl4 intoxication increased the expression 
of mRNAs, including MMP-2, MMP-9, TIMP-1, 
TIMP-2, TGF-β1, α-smooth muscle actin (SMA), and 
procollagen (Knittel et al., 2000). The synthesis of 
collagen leads to liver fibrosis. CCl4-induced liver injury 
involves the increased expression of TGF-β1 mRNA 
and hydroxyproline (the unique component of collagen) 
content, as observed in liver fibrosis.
Heptaprotective (ffect of A. cinnamomea 
)ruiting %odies $gainst CCl4-induced l/iver 
,njury
Hsiao et al. (2003) investigated the hepatoprotective 
activity of the water extract of A. cinnamomea fruiting 
bodies against CCl4-induced liver injury in ICR mice. 
Mice were subcutaneously injected with CCl4 (40% 
CCl4 diluted with olive oil, 0.1 mL/10 g BW) twice 
a week for 8 weeks to induce chronic chemical liver 
injury. Water extracts of A. cinnamomea fruiting bodies 
(0.25, 0.75, 1.25 mg/kg BW, day, 4 days a week) were 
orally administered for 8 weeks. The levels of plasma 
transaminases, i.e., AST and ALT, were significantly 
lower in the group of mice orally administered with the 
water extract of A. cinnamomea (1250 mg/mL) than 
in the corn oil control group, and were comparable to 
the silymarin positive group (100 mg/kg BW). The 
activities of hepatic superoxide dismutase and catalase 
were dose-dependently increased by treatment with the 
water extract of A. cinnamomea. The water extract of 
A. cinnamomea fruiting bodies showed an ability to 
scavenge 1,1-diphenyl-2-picrylhydrazyl radicals in an in 
vitro study (Hseu et al., 2008). Thus, the water extract 
of A. cinnamomea  fruiting bodies could effectively 
prevent CCl4-induced hepatotoxicity by scavenging the 
CCl4
Fruiting bodies of
A. cinnamomea
CCl3, CCl3OO
Inflammatory mediators
CYP2E1
Profibrogenic mediators
Lipid peroxidation
Liver injury
Liver fibrosis
Fruiting bodies of
A. cinnamomea
ЦTIMP-1
ЦTGF-ȕ1
Цcollagen 1
MMP-2 TIMP-1
MMP-9 TIMP-2
TGF-ȕ1 Į-SMA
Procollagen
Figure 3. Mechanisms of fruiting bodies of Antrodia Cinnamomea against CCl4-induced liver injuries.
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free radical formation or by inhibiting the inflammatory 
mediators in CCl4-mediated lipid peroxidation. The 
protective mechanisms of the fruiting bodies of A. 
cinnamomea against CCl4-induced liver injuries, liver 
fibrosis, and lipid peroxidation are shown in Figure 3.
Antrodia Cinnamomea and /iver &ancer
Hepatocellular carcinoma (HCC) is one of the most 
lethal malignancies worldwide, especially in Taiwan, 
China, Korea, and Sub-Saharan Africa (Marrero, 2006). 
When cancer cells become invasive and metastatic, the 
excess breakdown of the extracellular matrix (ECM) 
occurs (Christofori et al., 2006). MMP-2 and MMP-9, 
members of the MMP family that degrade the ECM 
during tissue remodeling, are believed to play important 
roles in the invasion and metastasis of liver cancers 
(Hofmann et al., 2005).
Protective (ffect of A. cinnamomea )ruiting 
Bodies Against Liver Cancer
Although the hepatoprotective effects of A. cinnamomea 
fruiting bodies and mycelia have been reported, studies 
on the effect of A. cinnamomea fruiting bodies in liver 
cancer are few. Hsu et al. (2005) reported the apoptotic 
effects of the ethyl acetate extract of A. cinnamomea 
fruiting bodies in human HCC cell lines (i.e., HepG2 
and PLC/PRF/5). They found that the extract inhibited 
cell survival signaling by increasing the expression of 
IκBα in the cytosol and decreasing the amount of NF-
κB in the nucleus, leading to the increased expression 
of Bcl-XL in both HepG2 and PLC/PRF/5 cells. Hsu et 
al. (2007) further reported the anti-invasion potential 
of the ethyl acetate extract of A. cinnamomea fruiting 
bodies in PLC/PRF/5 cells. This extract decreased the 
expression of MMP-2, MMP-9, membrane type 1-MMP, 
and vascular endothelial growth factor, which resulted 
in the anti-invasion effects on PLC/PRF/5 cells. Hsieh 
et al. (2010) isolated 3 triterpenoid compounds, antcin 
A, antcin C, and methyl antcinate A, from the fruiting 
bodies and investigated the growth-inhibitory effects 
of these 3 compounds in human liver cancer cells (i.e., 
HepG2, Hep3B, and Huh7). Methyl antcinate A showed 
more inhibitory activity than the other 2 compounds 
and was most potent in Huh7 cells. Methyl antcinate A 
decreased the levels of antiapoptotic proteins (i.e., Bcl-2 
and Bcl-XL), increased the cytochrome c  release from 
mitochondria to the cytosol, increased the mitochondrial 
translocation of cofilin and Bax, and enhanced 
NADPH activity in cells, suggesting that the apoptotic 
effects of methyl antcinate A were partially through a 
mitochondrial signaling pathway. These results indicated 
that methyl antcinate A isolated from A. cinnamomea 
fruiting bodies is a potential candidate in the treatment 
of HCC. Hsieh et al. (2011) further reported the 
apoptotic activities of antcin B and methylantcinate B, 
2 triterpenoids isolated from A. cinnamomea fruiting 
bodies. Antcin B and methylantcinate B both showed 
cytotoxicity in 3 HCC cell lines, i.e., HepG2, Hep3B, 
and Huh7. HepG2 showed more sensitivity to antcin B 
and methylantcinate B than the other cell lines and was 
further used for a mechanism study. Internucleosomal 
DNA fragmentation and subdiploid peak formation 
were observed in both antcin B and methylantcinate 
B-treated HepG2 cells, which suggested that both 
compounds triggered apoptotic cell death. The caspase 
activation and mitochondria-dependent pathways were 
both involved in the apoptosis induced by antcin B and 
methylantcinate B. The results indicated that antcin 
B and methylantcinate B induced NADPH oxidase-
provoked oxidative stress and extrinsic and intrinsic 
apoptosis, as a critical mechanism of causing cell death 
in HCC cells.
Protective Effect of A. cinnamomea Mycelia 
Against Liver Cancer
Not only the fruiting bodies but also the fermented 
mycelia of A. cinnamomea were investigated for their 
anticancer activities. Song et al. (2005a) reported the 
effect of the methanolic extract of mycelia (MEM) 
from a submerged culture of A. cinnamomea  on the 
inhibition of cell viability, as well as the mechanism 
of this effect. Antrodia Cinnamomea MEM inhibited 
the viability of liver cancer cells, i.e., HepG2 and 
Hep3B, in a dose-dependent manner. HepG2 cells 
showed more susceptibility to MEM than Hep3B 
cells. Furthermore, MEM had no significant inhibitory 
effect on normal primary rat hepatocytes. MEM 
induced DNA fragmentation in both HepG2 and 
Hep3B cells. However, G0/G1 cell cycle arrest was 
only observed in MEM-treated HepG2 cells. MEM 
resulted in the increase of caspase-3 and caspase-8 
proteolytic activities and induced the proteolysis of 
pro-caspase-8 and procaspase-3. The above results 
indicated that MEM induced HepG2 apoptosis through 
the activation of caspase-3 and caspase-8 cascades and 
the regulation of cell cycle progression. Furthermore, 
Song et al. (2005b) reported the effects of MEM on 
the Fas and Bcl-2 pathways. Since Fas belongs to 
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the TNF receptor (TNFR) superfamily, Fas ligands 
are known to induce apoptosis through Fas-induced 
caspase cascade activation, first caspase-8 followed by 
caspase-3 (Yoon et al., 2002). The expression of Fas 
was significantly increased in MEM-treated HepG2 
cells (Song et al., 2005b). The expression of death 
receptors (DR), including DR3, DR4, TNFRI, and 
TNFRII, were decreased by MEM in both a dose- and 
time-dependent manner. When HepG2 was treated 
with MEM, the expression of the antiapoptotic protein 
Bcl-2 was decreased but that of the proapoptotic 
protein Bcl-XL increased. The MEM-induced cell 
apoptosis possibly involves the upregulation of Fas 
expression, which promotes Fas and FasL ligation and 
then passes the death message to cytosolic messengers. 
Therefore, procaspase-8 is activated to caspase-8, 
thus triggering the caspase activation cascade. The 
studies of Song et al. (2005a,b) did not identify the 
active compounds that contribute to the anti-HCC 
effects of A. cinnamomea mycelia extracts. Lin et al. 
(2010) reported 4-acetylantroquinonol B isolated from 
the ethanolic extract of A. cinnamomea  mycelia to 
be the major antihepatoma constituent. The authors 
used antiproliferative activity-guided isolation to 
trace the active compound and identify its structure. 
4-Acetylantroquinonol B was purified and identified as 
the most potent compound to inhibit the proliferation 
of HepG2 cells. The authors also reported that the 
antiproliferation mechanism of 4-acetylantroquinonol 
B (Lin and Chiang, 2011) in HepG2 cells was through 
a dose-dependent cell cycle arrest at the G phase. In 
the G1 phase, cyclin D, cyclin E, CDK2, and CDK4/6 
work together to promote cell cycle progression. In 
4-acetylantroquinonol B-treated HepG2 cells, the 
protein expression of CDK2 and CDK4 was slightly 
decreased. p27, a cell-cycle regulator, was reported to 
be inactivated in HCC and considered a suppressor of 
liver cancer cells. The expression level of p27 in HepG2 
cells was increased by 4-acetylantroquinonol B. Thus, 
the growth-inhibitory effect of 4-acetylantroquinonol 
B was mostly mediated by cell cycle arrest through 
the decrease in CDK2 and CDK4 and increase in 
p27. Figure 4 shows the protective mechanisms of A. 
cinnamomea against liver cancer cells, including grow 
inhibition, apoptosis, and cell cycle arrest.
Fruiting bodies of
A. cinnamomea
Mycelia of A.
cinnamomea
Antcin B
Methylantcinate B
Antroquinonol
4-Acetyl antroquinonol
HepG2
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Ļ ROS
Ĺ HO-1
Ļ TNF-Į
Ĺ Nuclear Nrf-2
Methylantcinate A Huh7
Ĺ Bax
Ļ Bcl-2
Ļ Bcl-XL
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Hep3B
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Figure 4. Mechanisms of fruiting bodies, mycelia, and active compounds of Antrodia cinnamomea against liver cancer cells.
291
Liu et al . / Journal of Traditional and Complementary Medicine 2 (2012) 284-294
Active Compounds Against Liver Injury in the 
Fruiting Bodies and Mycelia of A. cinnamomea
Antrodia Cinnamomea fruiting bodies were reported 
to be rich in flavonoids, terpenoids, polyphenols, 
and polysaccharides (Chiang et al., 2010). In the 
study of Huang et al. (2010a), the authors used high-
performance liquid chromatography to analyze 
the components of the methanolic extract of A. 
cinnamomea fruiting bodies. Ten compounds were run 
under the same condition as standards to identify the 
chemical components in the sample, including ascorbic 
acid, 2,3-dimethoxy-5-methyl[1,4] benzoquinone, 
2,4,5-trimethoxybenzaldehyde (COX-2 inhibition, Chen 
et al., 2007), 4,7-dimethoxy-5-methyl-1,3-benzodioxide 
(antitumor, Tu et al., 2012), R,S -zhankuic acid C, 
dehydrosulphurenic acid (anti-inflammatory activity, 
Shen et al., 2007), R,S-zhankuic acid A, zhankuic 
acid B (anti-inflammatory activity, Shen et al., 2004), 
dehydroeburicoic acid (antileukemia, Du et al., 2012), 
and ergostatrien-3β-ol (anti-inflammation, Huang et 
al., 2010b). All 10 compounds were detected in the 
methanolic extract of the fruiting bodies. Wu et al. 
(2011) also analyzed the chemical contents of the A. 
cinnamomea fruiting body. According to their data, the 
fruiting bodies contain 0.24% polysaccharides, 12.95% 
triterpenoids, 0.3% total polyphenols, 0.05% flavonoids, 
and 0.015% condensed tannins.
Submerged fermentation or solid-state culture is 
a process extensively used for obtaining mycelia. 
Mycelial components such as maleic and succinic acid 
derivatives and triterpenoids were also investigated 
(Lu et al., 2011; Nakamura et al., 2004; Shao et al., 
2008). Nakamura et al. (2004) reported 5 new maleic 
and succinic acid derivatives together with ergosterol 
peroxide from A. cinnamomea  mycelia. Shao et al. 
(2008) identified 12 compounds from the methanolic 
extract of A. cinnamomea mycelia. Among them are 
4 new compounds: 10-hydroxy-γ-dodecalactone, 
11-hydroxy-γ-dodecalactone, 2-(2-hydroxyethyl)phenol, 
and 12-hydroxydodecanoic acid methyl ester; the other 
8 compounds were  ergosta t r ien-3β-ol  (ST-1) , 
ergosterol peroxide, methyl (4-hydroxyphenyl) acetate, 
vanillin, 4-hydroxybenzaldehyde, hexadecanoic 
acid, 5-methoxymethylfuran-2-carbaldehyde, and 
5-hydroxymethylfuran-2-carbaldehyde.
Lu et al. (2011) investigated the hepatoprotective 
effect of the fractions from ethanolic extracts of A. 
cinnamomea  mycelia and analyzed the composition 
of fractions (Fr-) I to III. Fr-I is a triterpenoid-
enriched fraction making up 359.8 mg per gram of 
mycelia. Fr-II is the polysaccharide content (483.1 
mg/g), which consists of rhamnose, arabinose, 
xylose, mannose, glucose, and galactose in a ratio 
of 0.11:0.23:0.06:0.77:0.29:1.00. Finally, Fr-III is a 
polyphenol-enriched fraction. The triterpenoid-enriched 
fraction, Fr-I, showed the best hepatoprotective activity 
against ethanol-induced acute liver injury in SD rats. 
However, the active compounds contributing to these 
hepatoprotective effects have not been reported up to 
now.
The active compounds isolated from A. cinnamomea 
shown to exhibit anti-liver cancer activities are listed 
in Table 2. Anticin A, anticin B, anticin C, and their 
derivatives methylantcinate A and methylantcinate 
B belong to  the  ergostane- type t r i terpenoids . 
Antroquinonol and 4-acetylantroquinonol B are 
ubiquinones. These compounds were reported to have 
anti-liver cancer activities in human hepatoma cell lines 
such as HepG2, Hep3B, and Huh7. As shown in Figure 
4, anticin B, methylantcinate A, methylantcinate B, 
and antroquinonol exerted apoptosis-inducing effects 
through the mitochondrial- or ROS-mediated pathways, 
whereas 4-acetylantroquinonol inhibited cell growth by 
activating cell cycle arrest.
Conclusion
Antrodia Cinnamomea  attracts much attention for 
its effectiveness in treating liver injuries, as shown 
in numerous published articles. The hepatoprotective 
effects of the fruiting bodies and mycelia of this 
mushroom have been investigated in animal models of 
ethanol- and CCl4-induced liver injury. The extracts of 
A. cinnamomea fruiting bodies and mycelia have also 
been investigated for their anti-liver cancer activities. 
Several active compounds were identified to have anti-
cancer activity in vitro.
The protective mechanisms of A. cinnamomea 
against ethanol-induced liver injuries were found to be 
through the inhibition of fatty acid synthesis and liver 
fibrosis (Figure 2). In addition, A. cinnamomea inhibited 
lipid peroxidation and liver fibrosis in CCl4-intoxicated 
animals (Figure 3). As for the anti-liver cancer effects, 7 
compounds from A. cinnamomea were found to inhibit 
cell growth by the activating apoptosis or cell cycle 
arrest in human hepatoma cells (Figure 4).
The present report provides scientific evidences 
for the use of A. cinnamomea  in ameliorating liver 
diseases. However, human clinical trials for studying the 
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Table 2. Compounds isolated from Antrodia Cinnamomea exhibiting anti-liver cancer activity.
Compounds Chemical structures References
4-Acetylantroquinonol B Lin and Chiang, 2011
Antroquinonol Kumar et al., 2011
Antcin B Hsieh et al., 2011
Methylantcinate B Hsieh et al., 2011
Antcin A Hsieh et al., 2010
Antcin C Hsieh et al., 2010
Methylantcinate A Hsieh et al., 2010
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effectiveness of A. cinnamomea are still ongoing (http://
clinicaltrials.gov/ct2/show/results/NCT01287286). The 
results of the studies described here suggest the potential 
of A. cinnamomea to prevent and treat liver diseases, as 
well as its potential to be developed into health foods or 
new drugs.
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